HRMY earnings: real EPS beat/miss history, analyst consensus Buy, P/E 13.83. Updated 2026-07-23.
Harmony Biosciences Holdings (HRMY) Research Hub
Harmony Biosciences Holdings (HRMY) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-09-11, shares last closed at 41.52 USD (-0.24%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 13.83, market cap 2.07B. This hub links to the full technical, earnings and options research available for HRMY.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 41.52 USD (-0.24%) |
| 52-week range | 32.25 USD – 43.49 USD |
| Trend regime | Range |
| 14-day RSI | 63.2 (Bullish) |
| Trailing P/E | 13.83 |
| Market cap | 2.07B |
| Dividend yield | 0.00% |
Available research for HRMY
Covered Call on HRMY: how it works, illustrative setup around the real 41.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HRMY: how it works, illustrative setup around the real 41.52 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HRMY: how it works, illustrative setup around the real 41.52 USD price, max profit/loss, breakeven and when to use it. Educational.
HRMY technical analysis: range, last 41.52 USD, RSI 63.2, 52w range 32.25 USD–43.49 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HRMY in?
Harmony Biosciences Holdings (HRMY) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is HRMY in an uptrend or downtrend?
As of 2026-09-11, HRMY is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HRMY's trailing P/E ratio?
HRMY's trailing P/E is 13.83, with a market cap of 2.07B. See the earnings research page for full valuation detail.